The board of directors for Thoratec (NSDQ:THOR) authorized a $200 million repurchase program for shares of the company’s common stock.
Wall Street Beat
Analogic’s shares flop as equipment delays sink Q1
Ex-Hansen Medical exec must face SEC charges
A former executive with Hansen Medical (NSDQ:HNSN) can’t get out of a lawsuit filed against him by the the U.S. Securities & Exchange Commission accusing him of hatching a scheme to artificially inflate Hansen’s revenues.
Edwards Lifesciences’ Sapien forecast misses expectations
A conservative forecast for 2014 sent shares of Edwards Lifesciences (NYSE:EW) down more than 5% yesterday and kept them flat today, as the medical device company said it expects more competition next year for its flagship Sapien replacement heart valve.
UPDATED: St. Jude to buy back $700M in outstanding shares, affirms outlook
St. Jude Medical’s (NYSE:STJ) announced that it has approval from its board of directors to buy back up to $700 million shares’ worth of its outstanding common stock, reporting in tandem that it expects to meet its revenue and per-share earnings guidance for the year.
Hologic hands corner office to former Stryker chief, takes on 2 Icahn board members
Medtech M&A: Covidien’s $860M buyout sends Given Imaging’s stock soaring
Cyberonics expands share buyback program
Cyberonics (NSDQ:CYBX) said it will expand its share repurchase program by an additional 1 million shares by the end of its 2015 fiscal year.
The silver lining on the medtech tax? | MassDevice.com On Call
MASSDEVICE ON CALL — The 2.3% sales tax enacted by the Affordable Care Act isn’t a fan favorite among medical device makers, but there may be room for investors to find new opportunities.
The tax may make young companies more attractive targets and patent portfolios more valuable, for example.
Lumenis files for $115M IPO
Lumenis Ltd., an Israeli medtech company that makes lasers used in eye surgery, urology and cosmetic medical procedures, filed today for an initial public offering worth $115 million.
Yokneam, Israel-based Lumenis said it plans to trade on the NASDAQ stock exchange under the "LMNS" symbol.